# PMV Pharmaceuticals, Inc.: Form 8-K, filed Oct 12, 2023

- Company: [PMV Pharmaceuticals, Inc.](/companies/pmvp.md) (CIK 1699382)
- Form: 8-K
- Filed: 2023-10-12
- Accepted by EDGAR: Oct 12, 2023, 21:02 ET
- Period: 2023-10-12
- Accession: 0001193125-23-255083
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1699382/000119312523255083/d534012d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1699382/000119312523255083/

## Items reported

- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1699382/000119312523255083/d534012d8k.htm

Filed Oct 12, 2023.
Source: SEC EDGAR, the filing index for accession 0001193125-23-255083. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.